Endeavor cardiovascular data

The Danish SORT OUT III trial showed that the 9-month target lesion revascularization (TLR) rate was 4% with Endeavor vs. 1% with Cypher sirolimus-eluting stent from Johnson & Johnson (NYSE:JNJ, Ne...